Curevac partners with Bayer Pharma to boost mRNA Covid vaccine
After BioNTech SE and Pfizer, Moderna and NIH, 3rd mRNA Covid vaccine player CureVac now partners with fellow German company Bayer Pharmaceuticals, to accelerate clinical, regulatory and supply.
Increased collaboration across the industry will be another major positive impact of Covid-19 crisis.
#postcovid19 #vaccinessavelives #innovation #launches
